Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00011349 · ClinicalTrials.gov registry record
Early Stage Prostate Cancer Cohort
A clinical trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 1,116
- Enrollment target
NCT00011349: Completed study, sponsored by US Department of Veterans Affairs.
NCT00011349 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 1,116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00011349 has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 1,116 participants
- Enrollment target
Study Summary
Environmental factors such as diet and cigarette smoking may play a role in predicting the progression of early stage prostate cancer to advance disease. The goal of this project is to establish an observational cohort of patients with early stage prostate cancer who elect not to undergo radical prostatectomy or radiation therapy to evaluate risk factors which predict the transformation of early stage to clinically aggressive disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,116 participants |
| Start Date | 2001-01 |
| Est. Completion | 2010-01 |
What the finished NCT00011349 record still lists
NCT00011349 is an observational study that tracks outcomes without assigning an intervention. Its 1,116 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00011349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00011349 about?
NCT00011349 is a clinical study titled "Early Stage Prostate Cancer Cohort". Environmental factors such as diet and cigarette smoking may play a role in predicting the progression of early stage prostate cancer to advance disease. The goal of this project is to establish an observational cohort of patients with early stage prostate cancer who elect not to undergo radical pro...
What is the current status of trial NCT00011349?
This trial is currently completed. The enrollment target is 1,116 participants. The study started on 2001-01. Estimated completion is 2010-01.
Who is sponsoring clinical trial NCT00011349?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia